Stimulus watch and of course, palantir, we are awaiting the opening trade set to begin really at any moment. Alex karp, the ceo will join us right here on cnbc immediately following the first trade, jon as we said, its been a long road a lot of filings. A lot to read about the company, voting structure, privacy, you name it. And the Business Model at large. Yeah. And its another big, big ipo but very different from snow flake, which we saw which has a ton of customers, large and small and kind of this very broad play on data in the cloud. This is a company thats dealing with big data and has just a few really huge customers, carl. And thats where well start this morning, jon. Josh lipton has more on what to expect once the first trade happens. Hey, josh. Carl, a master of creativity. That is how Ceo Alex Karp describes his company, palantir. A data miner, its software ahows customers to integrate volumes of data into a central platform where it can then be securely analyzed and interpr
Debut at the New York Stock Exchange that direct listing, we expect that debut to happen any moment now. Well show you that when that begins trading steve weiss, i begin with you, you have positive news today on virus therapeutics, some of the Economic Data was good as well you have made some interesting moves. You bought back ford, bought back peloton, corvo, and i want to know why. I also bought back some of the clean energy plays heres why i perhaps got too negative wos week vgts it seemed to me that the market has been digesting, given bidens movement in the polls consistently having even a lot of the swing states, so i thought that the debate was bidens to lose, knowing where trump was going to come from, he was well prepared. I thought thats what we got i did not count on the risk to my negative scenario was also stimul stimulus i did that count on the positive news of stimulus that we got overnight and this morning, which reversed the futures so, look, the other factor was that
0. 719 andrew and we have numbers to bring you this morning from United Health group just out with its quarterly numbers. Reporting Quarterly Earnings of 3. 51 per share. It beat the consensus estimate of 3. 09 revenue also above forecasts, saying that medical care trends that had been disrupted by the pandemic are moving closer to normal you are looking at that stock up just marginally this morning and we have three more financials, bank of america this hour, Goldman Sachs in the 7 00 hour and then wells fargo in the 8 00 hour. Joe. Thankthanks, andrew. Another Clinical Trial halted over safety concerns, eli lilly late stage trial has been paused by u. S. Health regulation tors it used a Health Sample from one the first patients recovered from coronavirus ill given you more details. Because it leaves out something important. Of the trials ongoing of the antibody, they decided to add remdesivir along with the antibody and that is when they had to halt the trial for some kind of safety
Strong gains and this morning you will see that there are green arrows once again, the dow indicated up by about 88, s p by about 9 1 2 and the nasdaq indicated up by 48 points if you watched what happened in the treasury markets, we did get a lot of fed speak and it sounds like there is a little bit of confusion. You can see the ten year note has ticked up a little bit, 0. 769 is the latest yield andrew and lets take a quick look at the dow transports, gaining another 2. 5 yesterday, also hitting a record high, the two as to beings to watch this morning, eli lilly and he regeneron both big winners on Covid Treatment hopes. And President Trump touting both of those in a video that he released over twitter late yesterday. Well tuck a lalk more about th. But also take a look at shares of tesla, new Street Research upgrading that Company Stock to a buy saying that to sees a decade of hyper growth ahead, this call makes the firm the second highest priced target on the street so in lead wit
Else, stimulus optimism. Pelosi and mnuchin are set to speak again. Airline stocks are up. Plus the race for a cure and treatment for the coronavirus. Shares of regeneron and eli lilly are rallying, both asking the fda for emergency use approval for their antibody therapies. And speaking of surging, look at shares of ibm this morning, moving up on plans to spin off its it infrastructure unit Arvind Krishna and Ginni Rometty will both join us first to discuss this historic move for the company. Carl we are awash in headlines from the president after this 55minute interview. But buried in there are discussions about the progress of stimulus talks and emergency approval for the likes of lilly and regeneron. Look, i think that there is a narrative that were going to start hearing and it was the president s narrative, he voiced it, i know if youre george ancopolous, you dont want to hear it is a cure. You want to hear it is something that is part of a cocktail of things that you need to be